Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1786 1
1787 1
1788 1
1790 1
1792 1
1797 1
1800 2
1804 1
1806 5
1807 2
1808 3
1809 2
1810 2
1811 1
1812 1
1852 1
1862 2
1863 3
1864 3
1865 1
1867 1
1868 1
1869 4
1870 1
1872 3
1873 1
1874 3
1875 2
1876 1
1883 1
1885 4
1886 2
1887 2
1888 2
1889 3
1890 2
1891 4
1892 1
1893 3
1894 3
1895 5
1896 4
1897 8
1898 4
1899 7
1900 4
1901 5
1902 6
1903 4
1904 2
1905 3
1906 3
1907 6
1908 3
1909 5
1910 3
1911 4
1912 5
1913 5
1914 9
1915 3
1916 2
1917 4
1918 1
1919 3
1920 1
1921 2
1922 1
1923 2
1925 1
1928 2
1935 1
1936 1
1937 1
1945 2
1946 2
1947 6
1948 1
1949 3
1950 1
1951 2
1952 5
1953 2
1954 5
1955 9
1957 3
1958 7
1959 5
1960 7
1961 10
1962 7
1963 4
1964 11
1965 28
1966 11
1967 7
1968 16
1969 23
1970 16
1971 19
1972 27
1973 11
1974 24
1975 15
1976 26
1977 22
1978 14
1979 25
1980 27
1981 23
1982 23
1983 24
1984 23
1985 42
1986 34
1987 45
1988 38
1989 41
1990 51
1991 44
1992 37
1993 53
1994 59
1995 54
1996 56
1997 57
1998 53
1999 55
2000 64
2001 69
2002 62
2003 48
2004 78
2005 95
2006 99
2007 123
2008 107
2009 120
2010 100
2011 95
2012 116
2013 138
2014 119
2015 130
2016 119
2017 125
2018 145
2019 151
2020 207
2021 227
2022 172
2023 158
2024 147
2025 164
2026 148

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,397 results

Results by year

Filters applied: . Clear all
Page 1
Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer.
Kunkler IH, Russell NS, Anderson N, Sainsbury R, Dixon JM, Cameron D, Loncaster J, Hatton M, Westenberg H, Clarke J, McCarty H, Evans R, Geropantas K, Wolstenholme V, Alhasso A, Woodings P, Barraclough L, Bayman N, Welch R, Muturi F, McEleney T, Burns J, Riddle K, Macdonald E, Dunlop J, Sergenson N, van Tienhoven G, Taylor KJ, Bartlett JMS, Piper T, Velikova G, Aird E, Chua B, Hurkmans C, Venables K, Williams LJ, Thomas JS, Hanby AM, Maclennan M, Cleator S, Verghese ET, Li Y, Wang S, Canney P; SUPREMO Trial Investigators; Sunil. Kunkler IH, et al. Among authors: clarke j. N Engl J Med. 2025 Nov 6;393(18):1771-1783. doi: 10.1056/NEJMoa2412225. N Engl J Med. 2025. PMID: 41191939 Free PMC article. Clinical Trial.
The overlapping global distribution of dengue, chikungunya, Zika and yellow fever.
Lim A, Shearer FM, Sewalk K, Pigott DM, Clarke J, Ghouse A, Judge C, Kang H, Messina JP, Kraemer MUG, Gaythorpe KAM, de Souza WM, Nsoesie EO, Celone M, Faria N, Ryan SJ, Rabe IB, Rojas DP, Hay SI, Brownstein JS, Golding N, Brady OJ. Lim A, et al. Among authors: clarke j. Nat Commun. 2025 Apr 10;16(1):3418. doi: 10.1038/s41467-025-58609-5. Nat Commun. 2025. PMID: 40210848 Free PMC article.
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.
Sands JM, Champiat S, Hummel HD, Paulson KG, Borghaei H, Alvarez JB, Carbone DP, Carlisle JW, Choudhury NJ, Clarke JM, Gadgeel SM, Izumi H, Navarro A, Lau SCM, Lammers PE, Huang S, Hamidi A, Mukherjee S, Owonikoko TK. Sands JM, et al. Among authors: clarke jm. Cancer. 2025 Feb 1;131(3):e35738. doi: 10.1002/cncr.35738. Cancer. 2025. PMID: 39876075 Free PMC article. Review.
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.
Gainor JF, Patel MR, Weber JS, Gutierrez M, Bauman JE, Clarke JM, Julian R, Scott AJ, Geiger JL, Kirtane K, Robert-Tissot C, Coder B, Tasneem M, Sun J, Zheng W, Gerbereux L, Laino A, Porichis F, Pollard JR, Hou P, Sehgal V, Chen X, Morrissey M, Daghestani HN, Feldman I, Srinivasan L, Frederick JP, Brown M, Aanur P, Meehan R, Burris HA 3rd. Gainor JF, et al. Among authors: clarke jm. Cancer Discov. 2024 Nov 1;14(11):2209-2223. doi: 10.1158/2159-8290.CD-24-0158. Cancer Discov. 2024. PMID: 39115419 Clinical Trial.
A Standardized Approach to Performing and Interpreting Functional Lumen Imaging Probe Panometry for Esophageal Motility Disorders: The Dallas Consensus.
Carlson DA, Pandolfino JE, Yadlapati R, Vela MF, Spechler SJ, Schnoll-Sussman FH, Lynch K, Lazarescu A, Khan A, Katz P, Jain AS, Gyawali CP, Gupta M, Garza JM, Fass R, Clarke JO, Chokshi RV, Chen J, Ravi K, Chan WW, Sultan S, Konda VJA. Carlson DA, et al. Among authors: clarke jo. Gastroenterology. 2025 Jun;168(6):1114-1127.e5. doi: 10.1053/j.gastro.2025.01.234. Epub 2025 Feb 4. Gastroenterology. 2025. PMID: 39914779 Free PMC article.
The Dubai Definition and Diagnostic Criteria of Laryngopharyngeal Reflux: The IFOS Consensus.
Lechien JR, Vaezi MF, Chan WW, Allen JE, Karkos PD, Saussez S, Altman KW, Amin MR, Ayad T, Barillari MR, Belafsky PC, Blumin JH, Johnston N, Bobin F, Broadhurst M, Ceccon FP, Calvo-Henriquez C, Eun YG, Chiesa-Estomba CM, Crevier-Buchman L, Clarke JO, Dapri G, Eckley CA, Finck C, Fisichella PM, Hamdan AL, Hans S, Huet K, Imamura R, Jobe BA, Hoppo T, Maron LP, Muls V, O'Rourke AK, Perazzo PS, Postma G, Prasad VMN, Remacle M, Sant'Anna GD, Sataloff RT, Savarino EV, Schindler A, Siupsinskiene N, Tseng PH, Zalvan CH, Zelenik K, Fraysse B, Bock JM, Akst LM, Carroll TL. Lechien JR, et al. Among authors: clarke jo. Laryngoscope. 2024 Apr;134(4):1614-1624. doi: 10.1002/lary.31134. Epub 2023 Nov 6. Laryngoscope. 2024. PMID: 37929860 Free article.
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.
Mellinghoff IK, Lu M, Wen PY, Taylor JW, Maher EA, Arrillaga-Romany I, Peters KB, Ellingson BM, Rosenblum MK, Chun S, Le K, Tassinari A, Choe S, Toubouti Y, Schoenfeld S, Pandya SS, Hassan I, Steelman L, Clarke JL, Cloughesy TF. Mellinghoff IK, et al. Among authors: clarke jl. Nat Med. 2023 Mar;29(3):615-622. doi: 10.1038/s41591-022-02141-2. Epub 2023 Feb 23. Nat Med. 2023. PMID: 36823302 Free PMC article. Clinical Trial.
Risks of epilepsy.
Clarke J, Johnston JA. Clarke J, et al. J Neurol. 2024 Oct;271(10):7054-7056. doi: 10.1007/s00415-024-12682-w. Epub 2024 Sep 11. J Neurol. 2024. PMID: 39259303 No abstract available.
Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non-Small-Cell Lung Cancer.
Riely GJ, Smit EF, Ahn MJ, Felip E, Ramalingam SS, Tsao A, Johnson M, Gelsomino F, Esper R, Nadal E, Offin M, Provencio M, Clarke J, Hussain M, Otterson GA, Dagogo-Jack I, Goldman JW, Morgensztern D, Alcasid A, Usari T, Wissel P, Wilner K, Pathan N, Tonkovyd S, Johnson BE. Riely GJ, et al. Among authors: clarke j. J Clin Oncol. 2023 Jul 20;41(21):3700-3711. doi: 10.1200/JCO.23.00774. Epub 2023 Jun 4. J Clin Oncol. 2023. PMID: 37270692 Clinical Trial.
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report.
Riely GJ, Ahn MJ, Clarke JM, Dagogo-Jack I, Esper R, Felip E, Gelsomino F, Goldman JW, Hussein M, Johnson M, Marrone KA, Morgensztern D, Nadal E, Negrao MV, Offin M, Provencio M, Ramalingam SS, Roof L, Sanborn RE, Smit EF, Tsao A, Usari T, Alcasid A, Wilner K, Tonkovyd S, Zhang X, Johnson BE. Riely GJ, et al. Among authors: clarke jm. J Thorac Oncol. 2025 Oct;20(10):1538-1547. doi: 10.1016/j.jtho.2025.05.023. Epub 2025 Jun 4. J Thorac Oncol. 2025. PMID: 40480428 Free PMC article. Clinical Trial.
4,397 results